選択的セロトニン再取り込み阻害薬(SSRI)およびセロトニン-ノルエピネフリン再取り込み阻害薬(SNRI)による片頭痛の予防 https://t.co/40UEOfVXGL
RT @DrMAlAteeq: Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is ob…
RT @DrMAlAteeq: Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is ob…
RT @DrMAlAteeq: Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is ob…
RT @DrMAlAteeq: Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is ob…
RT @DrMAlAteeq: Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is ob…
Cochrane review: SSRI and SNRI for prevention of migraine “The usefulness of SSRIs or SNRIs for preventing migraine is obscure and the best guess is that these drugs are unlikely to be effective for the majority of patients” https://t.co/2btkokditC
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults https://t.co/dn5k8TaZEa #painevidence #MigraineAwarenessWeek #MAW2019 https://t.co/HXaS00UKu0
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/SUlbyGq5f9 #PaPaStheme #migraine #painevidence (KH)
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/wQqglIRGB0 #PaPaStheme #migraine #painevidence (KH)
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/wQqglIRGB0 #PaPaStheme #migraine #painevidence (KH)
New @CochranePaPaS review: NO benefit for SSRIs or SNRIs for preventing adult #migraine http://t.co/t8aUI6kcYp http://t.co/Nl3AOK9a7M
New @CochranePaPaS review: NO benefit for SSRIs or SNRIs for preventing adult #migraine http://t.co/t8aUI6kcYp http://t.co/Nl3AOK9a7M
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/wQqglIRGB0 #PaPaStheme #migraine #painevidence (KH)
New @CochranePaPaS review: NO benefit for SSRIs or SNRIs for preventing adult #migraine http://t.co/t8aUI6kcYp http://t.co/Nl3AOK9a7M
New @CochranePaPaS review: NO benefit for SSRIs or SNRIs for preventing adult #migraine http://t.co/t8aUI6kcYp http://t.co/Nl3AOK9a7M
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/wQqglIRGB0 #PaPaStheme #migraine #painevidence (KH)
See 'SSRIs and SNRIs for the prevention of migraine in adults' http://t.co/wQqglIRGB0 #PaPaStheme #migraine #painevidence (KH)
@ACCESSSS2 we recently published an updated #Cochrane review on this topic: access it here http://t.co/3e3tZQL0V5 #painevidence
Inhibidores de recaptación de serotonina no previenen la migraña en adultos #Rev_Sist http://t.co/gGaY2iHadW @seneurologia @pontealdiaAP
SSRIs and SNRIs for the prevention of migraine in adults. http://t.co/5unEWuruNr
Actualización de RS Cochrane sobre eficacia preventiva de ISRS y venlafaxina en migraña de adultos: sin eficacia http://t.co/DBGOyhLCfe
ISRS y Venlafaxina no son superiores al placebo en el tratamiento preventivo de la migraña. http://t.co/qfUhQ8WCOP
「SSRIとSNRIと偏頭痛予防」トリプタン製剤の意義も知りたくなった SSRIs and SNRIs for the prevention of migraine in adults - The Cochrane Library http://t.co/JuPBpJ2PYa
Selective serotonin reuptake inhibitors (SSRIs) and serotoninnorepinephrine reuptake inhibitors (SNRIs) for the preve http://t.co/NW7wsEXvm9
Cochrane updated analysis: "the use of SSRIs and SNRIs for #migraine prophylaxis is not supported by evidence" http://t.co/C1TkBpirgA
Cochrane updated analysis: "the use of SSRIs and SNRIs for #migraine prophylaxis is not supported by evidence" http://t.co/C1TkBpirgA
Cochrane updated analysis: "the use of SSRIs and SNRIs for #migraine prophylaxis is not supported by evidence" http://t.co/C1TkBpirgA
Cochrane updated analysis: "the use of SSRIs and SNRIs for #migraine prophylaxis is not supported by evidence" http://t.co/C1TkBpirgA